Gilead Sciences
GILD
#128
Rank
S$200.18 B
Marketcap
S$161.34
Share price
0.38%
Change (1 day)
27.53%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): S$12.94 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are S$29.08 Billion. In 2024 the company made an earning of S$0.88 Billion a decrease over its 2023 earnings that were of S$8.80 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$12.94 B1361.33%
2024 S$0.88 B-89.94%
2023 S$8.80 B17.97%
2022 S$7.46 B-29.77%
2021 S$10.62 B395.99%
2020 S$2.14 B-67.66%
2019 S$6.62 B-33.84%
2018 S$10.01 B-42.35%
2017 S$17.36 B-20.87%
2016 S$21.94 B-21.06%
2015 S$27.80 B45.8%
2014 S$19.07 B253.01%
2013 S$5.40 B16.51%
2012 S$4.63 B-1.07%
2011 S$4.68 B-6.71%
2010 S$5.02 B11.75%
2009 S$4.49 B29.5%
2008 S$3.47 B19.11%
2007 S$2.91 B-455.74%
2006 -S$0.82 Billion-154.93%
2005 S$1.49 B76.99%
2004 S$0.84 B-266.16%
2003 -S$0.51 Billion-638.24%
2002 S$94.22 M31.5%
2001 S$71.65 M-242.15%
2000 -S$50.42 Million-40.2%
1999 -S$84.3 Million31.85%
1998 -S$63.94 Million8.73%
1997 -S$58.8 Million27.22%
1996 -S$46.22 Million
1994 -S$44.04 Million26.57%
1993 -S$34.8 Million46.49%
1992 -S$23.76 Million362.5%
1991 -S$5.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$10.58 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$5.72 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.13 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.27 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.44 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.21 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.58 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.89 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.64 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA